| 1. |
- Cossarizza, A., et al.
(författare)
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- 2019
-
Ingår i: European Journal of Immunology. - : Wiley. - 0014-2980 .- 1521-4141. ; 49:10, s. 1457-1973
-
Tidskriftsartikel (refereegranskat)abstract
- These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community. They provide the theory and key practical aspects of flow cytometry enabling immunologists to avoid the common errors that often undermine immunological data. Notably, there are comprehensive sections of all major immune cell types with helpful Tables detailing phenotypes in murine and human cells. The latest flow cytometry techniques and applications are also described, featuring examples of the data that can be generated and, importantly, how the data can be analysed. Furthermore, there are sections detailing tips, tricks and pitfalls to avoid, all written and peer-reviewed by leading experts in the field, making this an essential research companion.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Magallon, D, et al.
(författare)
-
European expert network for the reduction of uncertainties in severe accident safety issues (EURSAFE)
- 2005
-
Ingår i: Nuclear Engineering and Design. - : Elsevier BV. - 0029-5493 .- 1872-759X. ; 235:2-4, s. 309-346
-
Tidskriftsartikel (refereegranskat)abstract
- EURSAFE thematic network was a concerted action in the sixth framework programme of the European Commission. It established a large consensus among the main actors in nuclear safety on the severe accident issues where large uncertainties still subsist. The conclusions were derived from a first-of-kind phenomena identification and ranking tables (PIRT) on all aspects of severe accident also realised in the frame of the project. Starting from a list of all severe accident phenomena containing approximately 1000 entries and established by the twenty partner organisations, 106 phenomena were retained eventually as both important for safety and still lacking sufficient knowledge. Ultimately, 21 research areas for addressing these phenomena regrouped according to their similarities were identified. A networking structure for implementing and executing the necessary research was proposed, which promotes integration and harmonisation of the different national programmes. A severe accident database structure was proposed to ensure preservation of experimental data and enhanced communication for data exchange and use for severe accident codes assessment. The final product, named EURSAFE, is a website network, http://asa2.jrc.it/eursafe, connecting nodes located at partner sites. As the result of an action involving R&D governmental institutions, regulatory bodies, nuclear industry, utilities and universities from six EU Member States (Finland, France, Germany, Spain, Sweden, UK) plus JRC, three European third countries (Czech Republic, Hungary, Switzerland), and USA, EURSAFE represents a significant step towards harmonisation and credibility of the approaches, and resolution of the remaining severe accident issues.
|
|
| 5. |
|
|
| 6. |
- Papadopoulos, Nikolaos G, et al.
(författare)
-
Research needs in allergy: an EAACI position paper, in collaboration with EFA.
- 2012
-
Ingår i: Clinical and translational allergy. - : Wiley. - 2045-7022. ; 2:1
-
Tidskriftsartikel (refereegranskat)abstract
- ABSTRACT: In less than half a century, allergy, originally perceived as a rare disease, has become a major public health threat, today affecting the lives of more than 60 million people in Europe, and probably close to one billion worldwide, thereby heavily impacting the budgets of public health systems. More disturbingly, its prevalence and impact are on the rise, a development that has been associated with environmental and lifestyle changes accompanying the continuous process of urbanization and globalization. Therefore, there is an urgent need to prioritize and concert research efforts in the field of allergy, in order to achieve sustainable results on prevention, diagnosis and treatment of this most prevalent chronic disease of the 21st century.The European Academy of Allergy and Clinical Immunology (EAACI) is the leading professional organization in the field of allergy, promoting excellence in clinical care, education, training and basic and translational research, all with the ultimate goal of improving the health of allergic patients. The European Federation of Allergy and Airways Diseases Patients' Associations (EFA) is a non-profit network of allergy, asthma and Chronic Obstructive Pulmonary Disorder (COPD) patients' organizations. In support of their missions, the present EAACI Position Paper, in collaboration with EFA, highlights the most important research needs in the field of allergy to serve as key recommendations for future research funding at the national and European levels.Although allergies may involve almost every organ of the body and an array of diverse external factors act as triggers, there are several common themes that need to be prioritized in research efforts. As in many other chronic diseases, effective prevention, curative treatment and accurate, rapid diagnosis represent major unmet needs. Detailed phenotyping/endotyping stands out as widely required in order to arrange or re-categorize clinical syndromes into more coherent, uniform and treatment-responsive groups. Research efforts to unveil the basic pathophysiologic pathways and mechanisms, thus leading to the comprehension and resolution of the pathophysiologic complexity of allergies will allow for the design of novel patient-oriented diagnostic and treatment protocols. Several allergic diseases require well-controlled epidemiological description and surveillance, using disease registries, pharmacoeconomic evaluation, as well as large biobanks. Additionally, there is a need for extensive studies to bring promising new biotechnological innovations, such as biological agents, vaccines of modified allergen molecules and engineered components for allergy diagnosis, closer to clinical practice. Finally, particular attention should be paid to the difficult-to-manage, precarious and costly severe disease forms and/or exacerbations. Nonetheless, currently arising treatments, mainly in the fields of immunotherapy and biologicals, hold great promise for targeted and causal management of allergic conditions. Active involvement of all stakeholders, including Patient Organizations and policy makers are necessary to achieve the aims emphasized herein.
|
|
| 7. |
- Van Dorsselaere, J. -P, et al.
(författare)
-
Sustainable integration of EU research in severe accident phenomenology and management
- 2011
-
Ingår i: Nuclear Engineering and Design. - : Elsevier BV. - 0029-5493. ; 241:9, s. 3451-3460
-
Tidskriftsartikel (refereegranskat)abstract
- In order to optimise the use of the available means and to constitute sustainable research groups in the European Union, the Severe Accident Research NETwork of Excellence (SARNET) has gathered, between 2004 and 2008, 51 organizations representing most of the actors involved in severe accident (SA) research in Europe plus Canada. This project was co-funded by the European Commission (EC) under the 6th Euratom Framework Programme. Its objective was to resolve the most important pending issues for enhancing, in regard of SA, the safety of existing and future nuclear power plants (NPPs). SARNET tackled the fragmentation that existed between the national R&D programmes, in defining common research programmes and developing common computer codes and methodologies for safety assessment. The Joint Programme of Activities consisted in:Implementing an advanced communication tool for accessing all project information, fostering exchange of information, and managing documents;Harmonizing and re-orienting the research programmes, and defining new ones;Analyzing the experimental results provided by research programmes in order to elaborate a common understanding of relevant phenomena;Developing the ASTEC code (integral computer code used to predict the NPP behaviour during a postulated SA) by capitalizing in terms of physical models the knowledge produced within SARNET;Developing scientific databases, in which the results of research experimental programmes are stored in a common format;Developing a common methodology for probabilistic safety assessment of NPPs;Developing short courses and writing a text book on severe accidents for students and researchers;Promoting personnel mobility amongst various European organizations. This paper presents the major achievements after four and a half years of operation of the network, in terms of knowledge gained, of improvements of the ASTEC reference code, of dissemination of results and of integration of the research programmes conducted by the various partners. Most initial objectives were reached but the continuation of the SARNET network, co-funded by EC in the 7th Framework Programme (SARNET2 project that started in April 2009 for 4 years), will consolidate the first assets and focus mainly on the highest priority pending issues as determined during the first period. The objective will be also to make the network evolve towards a complete self-sustainability.
|
|
